학술논문

217P Feasibility of quantitative sensory testing (QST) in clinical routine as a tool to evaluate chemotherapy-induced peripheral neuropathy (CIPN) amongst breast cancer patients treated with taxanes.
Document Type
Article
Source
Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p. 1 Chart.
Subject
*BREAST cancer patients
*PERIPHERAL neuropathy
*PAIN threshold
Language
ISSN
0923-7534